CAT and oral cavity squamous cell carcinoma: CD59 has been evaluated as a salivary biomarker for oral squamous cell carcinomas together with M2BP, S100A9/MRP14, and catalase, achieving diagnostic sensitivity of 90%, specificity of 83%, and AUROCC of 0.93 for OSCC detection [144,145].